Author: Customer Service

ATHENS, Greece, April 16, 2026 (GLOBE NEWSWIRE) — Performance Shipping Inc. (NASDAQ: PSHG), (“we” or the “Company”), a global shipping company specializing in the ownership of tanker vessels, today announced that it has entered into time charter agreements with Repsol Trading S.A. (“Repsol”) for its two previously announced 158,000 dwt Suezmax tanker newbuilding vessels (the “Vessels”) under construction in China, by China Shipbuilding Trading Co. Ltd. and Shanghai Waigaoqiao Shipbuilding Co. Ltd. Under the agreements, the first vessel has been chartered for a period of seven (7) years (±30 days) at a daily hire rate of US$35,000, while the second vessel has been chartered for a period of five (5) years (±30 days) at a daily hire rate of US$36,850, payable monthly in advance. The Vessels are expected to be delivered from the shipyard...

RA’ANANA, Israel, April 16, 2026 (GLOBE NEWSWIRE) — Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (“Inspira” or the “Company”), today announced the successful delivery and acceptance of an Additively Manufactured Electronics (“AME”) system at a Tier-1 U.S. defense customer site under a commercial agreement. The customer site operates within a broader ecosystem of strategic defense initiatives, including quantum computing, quantum networking, integrated photonics, and superconducting systems. Advancing these sophisticated fields requires overcoming critical hardware bottlenecks, particularly regarding complex component integration and extreme miniaturization. Inspira’s AME platform is purposefully built for these constraints, enabling the rapid fabrication of highly integrated...

Exceptional measures of efficacy observed in THIO-101 Phase 2 trial to date include disease control, response rates, and survival data well above standard of care benchmarks 50,000 advanced NSCLC diagnoses in the U.S. annually CHICAGO, April 16, 2026 (GLOBE NEWSWIRE) — MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today announced that it has activated the first U.S. clinical site in its Phase 2 THIO-101 expansion trial of its lead investigational therapy as a third-line (3L) treatment for non-small cell lung cancer (NSCLC). “We are thrilled to activate the expansion of our Phase 2 THIO-101 trial in the U.S., bringing our novel treatment to our country’s broad underserved NSCLC patient population. Every...

Philips Verida detector-based spectral CT – 01Philips Verida detector-based spectral CTPhilips Verida detector-based spectral CT – 02Philips Verida detector-based spectral CTPhilips Verida detector-based spectral CT – 03Philips Verida detector-based spectral CTApril 16, 2026 Combining always-on spectral imaging with AI reconstruction to deliver enhanced levels of image quality, efficiency, and clinical insight across radiology, cardiology, and oncology Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has received U.S. Food and Drug Administration 510(k) clearance for the Philips Spectral CT Verida system, bringing its next-generation, AI-powered spectral CT innovation to the United States. AI-based reconstruction integrated...

EATONTOWN, N.J., April 16, 2026 (GLOBE NEWSWIRE) — Climb Global Solutions, Inc. (NASDAQ:CLMB) (“Climb” or the “Company”), a value-added global IT channel company providing unique sales and distribution solutions for innovative technology vendors, will host a conference call on Thursday, April 30, 2026 at 8:30 a.m. Eastern time to discuss its financial results for the first quarter ended March 31, 2026. The Company’s results will be reported in a press release prior to the call. Climb’s management will host the conference call, followed by a question-and-answer period. Interested parties may submit questions to the Company prior to the call by emailing CLMB@elevate-ir.com. Date: Thursday, April 30, 2026Time: 8:30 a.m. Eastern timeToll-free dial-in number: (800) 245-3047International dial-in number: (203) 518-9765Conference ID: CLIMBWebcast: Climb’s...

Activates the Distribution Layer of Its Flywheel, With Food Channel as the First Proof of a Scalable, Content-Driven Commerce System NEWPORT BEACH, Calif., April 16, 2026 (GLOBE NEWSWIRE) — Amaze Holdings, Inc. (NYSE American: AMZE) (“Amaze” or the “Company”), a global leader in creator-powered commerce, today announced the activation of its distribution engine as part of its strategy to build infrastructure for commerce inside content. The “creator economy” is already valued at more than $300B in 2026, and projected to grow to approximately $2T by 2035*, reshaping how individuals build audiences, brands, and businesses. While content has captured consumer attention at scale, it has not consistently converted that attention into commerce — resulting in fragmented conversion, low retention, and limited long-term value. Amaze is addressing...